• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Page 5 > Resources

Scientific articles

Page 5 > Resources

Scientific articles

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

news type

By Disease

diseases

Topic

By Topic

topic type

Location

By Location

location-news

Date Range

By Year

date range filter – slider
1999 — 2026

Results

No results found. Please try using different filter option(s).

In the media
8 Jul 2026

No medicine for dengue yet, Serum Institute’s new treatment is headed for global trials

The Print
Viewpoints
3 Aug 2026

A new chapter for African medical innovation

Nature Africa
Daily Nation logo
In the media
1 Aug 2026

End of painful injections as Kenya set to adopt new 14-day Kala-azar treatment

Daily Nation
New Vision logo
In the media
30 Jul 2026

WHO approves new shorter, less painful Kala-azar treatment for East Africa

New Vision
Viewpoints
30 Jul 2026

Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases

Stat News
Leishmaniasis patient Monica Lomoler carrying a bunch of firewood
Press releases
29 Jul 2026

WHO recommends new, better and safer treatment regimens for leishmaniasis

Press releases
27 Jul 2026

DNDi leadership to change in 2027

Stories
16 Jul 2026

Annie Liang: How students’ advocacy helped bring mycetoma out of the shadows

Publications
16 Jul 2026

DNDi 2025 Annual Report

The Telegraph
In the media
15 Jul 2026

Dengue outbreak complicates Bangladesh measles crisis response

The Telegraph
Laboratory of Medicinal and Computational Chemistry (LQMC), São Paulo University USP, São Carlos Campus, São Paulo Brazil.
Press releases
13 Jul 2026

DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security 

Chepokarial Rubben attentively cares for her five-year-old son, Romanu Kiptoo, at the kala-azar ward of Kacheliba Sub-County Referral Hospital in West Pokot County, Kenya. She gently soothes him, offering comfort as he endures the painful treatment for kala-azar.
Press releases
13 Jul 2026

DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals

Scientific articles
9 Jul 2026

Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring

PLOS Neglected Tropical Diseases
The Indian Express logo
In the media
9 Jul 2026

Serum Institute of India ties up with DNDi for Phase III trial of dengue therapy

The Indian Express
Press Releases Translations
8 Jul 2026

Brasil, Malásia e Tailândia estão prestes a iniciar ensaio clínico para testar tratamento promissor contra a dengue desenvolvido pelo Instituto Serum da Índia

Press Releases Translations
8 Jul 2026

Brasil, Malasia y Tailandia están a punto de iniciar ensayos clínicos para probar un prometedor tratamiento contra el dengue desarrollado por el Serum Institute of India

loading
Loading...
Scientific articles
11 Mar 2025

Unsupervised machine learning identifies biomarkers of disease progression in post-kala-azar dermal leishmaniasis in Sudan

PLOS Neglected Tropical Diseases
Scientific articles
25 Feb 2025

Patient insights research exploring disease awareness, patient life experience, and current management of visceral leishmaniasis in Bihar, India

PLOS Neglected Tropical Diseases
Scientific articles
25 Feb 2025

Model-informed drug development of a sustained release formulation of flucytosine in the treatment of cryptococcal meningitis: A case study using physiologically based pharmacokinetic modeling

CPT Pharmacometrics & Systems Pharmacology
Scientific articles
4 Feb 2025

Global health initiatives and mycetoma management: the unmet promise

Transactions of The Royal Society of Tropical Medicine and Hygiene
Scientific articles
1 Feb 2025

24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation

The Lancet Global Health
Scientific articles
25 Jan 2025

Severe dengue–related deaths in the elderly population soared in Southern Brazil in 2024

IJID Regions
Scientific articles
24 Jan 2025

The STROGHAT study protocol: An intervention study to evaluate safety, effectiveness and feasibility of treating gambiense HAT seropositive subjects with acoziborole

Open Research Europe
Scientific articles
10 Jan 2025

Congenital Chagas disease: A cohort study to assess molecular diagnostic methods at the Chagas disease national reference center of Argentina

PLOS Neglected Tropical Diseases
Scientific articles
20 Dec 2024

Challenges of sharing individual participant data for secondary research on neglected tropical diseases: the experience of Drugs for Neglected Diseases initiative and a call for action

BMJ Open
Scientific articles
3 Dec 2024

Early assessment of antibodies decline in Chagas patients following treatment using a serological multiplex immunoassay

Nature Communications
Scientific articles
12 Nov 2024

Development and validation of ultra-performance liquid chromatography tandem mass spectrometry methods for the quantitative analysis of the antiparasitic drug DNDI-6148 in human plasma and various mouse biomatrices

Journal of Chromatography B
Scientific articles
9 Nov 2024

Changes in lipid abundance are associated with disease progression and treatment response in chronic Trypanosoma cruzi infection

Parasites Vectors
Scientific articles
22 Oct 2024

Climate change, migration, and health: perspectives from Latin America and the Caribbean

The Lancet Regional Health – Americas
Scientific articles
17 Oct 2024

Immunotherapeutic strategies as potential treatment options for cutaneous leishmaniasis

Vaccines
Scientific articles
8 Oct 2024

Discovery of a series of macrocycles as potent inhibitors of Leishmania Infantum

Journal of Medicinal Chemistry
Scientific articles
25 Sep 2024

The promise of health for all: a collaborative model to close treatment gaps for neglected diseases

Clinical Pharmacology and Therapeutics
1 2 … 43 ›

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Youtube Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license